Simultaneous with the government’s decision to regulate all medical devices under the act, the NPPA has also stated that all medical devices would be governed under the Drugs (Prices Control) Order, 2013, with effect from April 1.
Please click here to read the full article.
Rupinder specializes in mergers & acquisitions, private equity investments, joint ventures, strategic alliances, cross-border investments, regulatory issues for India entry, restructurings of Indian and international conglomerates, as well as compliance and white-collar crime investigations.